Harrow Inc (HROW) Unusual Options Activity Today

Checking HROW unusual options activity helps you spot when traders are making outsized bets on Harrow Inc before the broader market catches on. Harrow Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor HROW unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching HROW unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking HROW unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and HROW unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products.

Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Catalysts rarely arrive without a footprint, and HROW unusual options activity is often where that footprint shows up first. Our scanner tracks Harrow Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at HROW unusual options volume on the call side or chasing put sweeps, Harrow Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.